NEXTSOURCE BIOTECHNOLOGY
Live / Registered — Registered (as of 18 Oct 2022)
What this means for you
Registered since 18 Oct 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97035793
- Registration number
- 6876715
- Mark type
- Design + words
- Filed
- 20 Sept 2021
- Published for opposition
- 02 Aug 2022
- Registered
- 18 Oct 2022
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders for use in human and veterinary medicine; Pharmaceutical preparation for skin care for use in human and veterinary medicine; Vaccines; Veterinary vaccines
Owner
- AZURITY PHARMACEUTICALS, INC., WOBURN, MA, US
- NextSource Biotechnology, LLC, Miami, FL, US
- NextSource Biotechnology, LLC, Miami, FL, US
- NextSource Biotechnology, LLC, Miami, FL, US
Prosecution history
- 05 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 May 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 02 Aug 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Aug 2022 — PUBLISHED FOR OPPOSITION
- 13 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jun 2022 — EXAMINER'S AMENDMENT ENTERED
- 23 Jun 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 23 Jun 2022 — EXAMINERS AMENDMENT E-MAILED